Recombinant Human ICOSLG Protein (Ala19-Thr139), C-hFc-tagged

Product Description

Cat

IMP-10421

Official Symbol

ICOSLG

Product Overview

Recombinant human B7-H2 Isoform 3 protein (Ala19-Thr139) with a Human IgG1 (Pro100-Lys330) Fc tag at C-terminus was expressed in Mouse myeloma cell line.

Description

Enables identical protein binding activity. Predicted to be involved in T cell receptor signaling pathway and positive regulation of interleukin-4 production. Located in cytoplasmic ribonucleoprotein granule and plasma membrane.

Expression System

Mouse myeloma cell line

Species

Human

Tag

C-hFc

Predicted N Terminal

Ala19

Form

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.

Molecular Mass

Predicted Molecular Mass: 40 kDa
SDS-PAGE: 57-66 kDa, reducing conditions

Protein length

Ala19-Thr139

Bio-activity

Measured by its binding ability in a functional ELISA. When Recombinant Human ICOS Fc Chimera is immobilized at 5 μg/mL, Recombinant Human B7-H2 Isoform 3 Fc Chimera binds with an ED50 of 10-50 μg/mL.

Endotoxin

<0.10 EU/μg of the protein by the LAL method.

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.

Notes

Disulfide-linked homodimer

Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, ≤ -20 centigrade as supplied.
1 month, 2 to 8 centigrade under sterile conditions after reconstitution.
3 months, ≤ -20 centigrade under sterile conditions after reconstitution.

Reconstitution

Reconstitute at 500 μg/mL in PBS.

SDS-PAGE

Data Sheet MSDS

Datasheet MSDS

For research or industrial raw materials, not for personal medical use!

Online Inquiry